Publications by authors named "Ke-Bin Zeng"

Background: Edaravone is a widely used treatment for patients with cerebral infarction and, in most cases, edaravone-induced side effects are mild. However, edaravone-related adverse reactions have been receiving increasing attention.

Case Summary: We treated three patients with acute cerebral infarction who died following treatment with edaravone.

View Article and Find Full Text PDF
Article Synopsis
  • ERK1/2 is phosphorylated and activated during environmental stress, like epileptiform discharge, influencing abnormal axon growth and synapse changes in neurons.
  • Neurons were tested in a controlled environment without magnesium, and the effects of the ERK1/2 inhibitor U0126 were compared at various time points following discharge.
  • The presence of phosphorylated ERK1/2, C-fos, GAP-43, and synaptophysin increased together after discharge, while inhibition of ERK1/2 led to a reduction in these markers, suggesting ERK1/2's role in promoting changes related to epilepsy.
View Article and Find Full Text PDF